Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

This study has been completed.

Study NCT01076530 Information provided by National Cancer Institute (NCI)

First Received on February 25, 2010. Last Updated on May 1, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Childhood Choroid Plexus Tumor
Childhood Craniopharyngioma
Childhood Ependymoblastoma
Childhood Grade I Meningioma
Childhood Grade II Meningioma
Childhood Grade III Meningioma
Childhood Infratentorial Ependymoma
Childhood Medulloepithelioma
Childhood Mixed Glioma
Childhood Oligodendroglioma
Childhood Supratentorial Ependymoma
Extra-adrenal Paraganglioma
Recurrent Childhood Ependymoma
Recurrent Childhood Medulloblastoma
Recurrent Childhood Pineoblastoma

More general conditions related to this trial

Adenocarcinoma
Bone Diseases
Bone Neoplasms
Brain Diseases
Carcinoma
Central Nervous System Diseases
Central Nervous System Neoplasms
Cerebral Ventricle Neoplasms
Cranial Nerve Diseases
Cranial Nerve Neoplasms
Eye Diseases
Gestational Trophoblastic Neoplasms
Meningeal Neoplasms
Mesonephroma
Musculoskeletal Diseases
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Complex and Mixed
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neoplasms, Vascular Tissue
Nervous System Diseases
Nervous System Neoplasms
Neuroendocrine Tumors
Optic Nerve Diseases
Optic Nerve Neoplasms
Peripheral Nervous System Neoplasms
Pregnancy Complications
Pregnancy Complications, Neoplastic
Spinal Cord Diseases
Trophoblastic Neoplasms

Interventions listed in this trial

vorinostat
temozolomide
pharmacological study

Additional drug interventions recognized in this trial

Dacarbazine

More general drug interventions related to this trial

Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Enzyme Inhibitors
Histone Deacetylase Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses

Sponsors listed in this trial

National Cancer Institute (NCI)

Back to top of Main Content